Practical Considerations for Treating Patients With Cancer in the COVID-19 Pandemic
Authors
Eva Segelov
Craig Underhill
Hans Prenen
Christos Karapetis
Christopher Jackson
Louise Nott
Tim Clay, Edith Cowan UniversityFollow
Nick Pavlakis
Sabe Sabesan
Ellen Heywood
Christopher Steer
Carrie Lethborg
Hui K. Gan
Desmond Yip
Narayan Karanth
Deme Karikios
C. Raina MacIntyre
Document Type
Journal Article
Publication Title
JCO Oncology Practice
Volume
16
Issue
8
First Page
467
Last Page
482
PubMed ID
32401686
Publisher
American Society of Clinical Oncology
School
School of Medical and Health Sciences
RAS ID
35238
Funders
https://ascopubs.org/doi/10.1200/OP.20.00229
Abstract
Cancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.
DOI
10.1200/OP.20.00229
Access Rights
free_to_read
Comments
Segelov, E., Underhill, C., Prenen, H., Karapetis, C., Jackson, C., Nott, L., ... & Raina MacIntyre, C. (2020). Practical considerations for treating patients with cancer in the COVID-19 pandemic. JCO Oncology Practice, 16(8), 467-482. https://doi.org/10.1200/OP.20.00229